Tessera Therapeutics Highlights Advances Across In Vivo Programs for Sickle Cell Disease and T-Cell Therapies at the 66th American Society of Hematology Annual Meeting
December 09, 2024 12:05 ET | Source: Tessera Therapeutics In vivo proof-of-concept…
Slurp Culinary Academy Transforming Culinary Education with Practical, Fast-Track Programs in Bengaluru
BENGALURU, India, Dec. 4, 2024 /PRNewswire/ -- Slurp Culinary Academy, based in…
NABH INTEGRATES FOGSI’S MATERNAL HEALTH STANDARDS ACROSS ITS CERTIFICATION PROGRAMS
The MoU signed in 2022 has progressed and culminated in the subsumption of…
Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024
SAN FRANCISCO, Nov. 17, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq:…
NABH INTEGRATES FOGSI’S MATERNAL HEALTH STANDARDS ACROSS ITS CERTIFICATION PROGRAMS
The MoU signed in 2022 has progressed and culminated in the subsumption of…
NABH INTEGRATES FOGSI’S MATERNAL HEALTH STANDARDS ACROSS ITS CERTIFICATION PROGRAMS
The MoU signed in 2022 has progressed and culminated in the subsumption of…
NABH INTEGRATES FOGSI’S MATERNAL HEALTH STANDARDS ACROSS ITS CERTIFICATION PROGRAMS
The MoU signed in 2022 has progressed and culminated in the subsumption of…
Medicenna Presents Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
November 08, 2024 10:00 ET | Source: Medicenna Therapeutics Corp. MDNA113…